Peptone operates as a translational biophysics company. The company focuses on the discovery of novel therapeutics targeting disordered proteins, which lack rigid three-dimensional (3D) structures but play critical roles in biological processes. It primarily serves the healthcare and pharmaceutical industries. It was founded in 2018 and is based in London, United Kingdom.